These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 75197)
1. Origin and evolution of benign prostatic enlargement. McNeal JE Invest Urol; 1978 Jan; 15(4):340-5. PubMed ID: 75197 [TBL] [Abstract][Full Text] [Related]
2. Pathology of benign prostatic hyperplasia. Insight into etiology. McNeal J Urol Clin North Am; 1990 Aug; 17(3):477-86. PubMed ID: 1695776 [TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Leav I; McNeal JE; Ho SM; Jiang Z Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556 [TBL] [Abstract][Full Text] [Related]
4. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen. Ho CK; Nanda J; Chapman KE; Habib FK J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814 [TBL] [Abstract][Full Text] [Related]
6. The origin and development of benign prostatic hyperplasia. An age-dependent process. Oesterling JE J Androl; 1991; 12(6):348-55. PubMed ID: 1722790 [TBL] [Abstract][Full Text] [Related]
8. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699 [TBL] [Abstract][Full Text] [Related]
9. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate. Shakya G; Malla S; Shakya KN Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207 [TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Oesterling JE Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233 [TBL] [Abstract][Full Text] [Related]
13. [An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate]. Liu X; Tang J; Yang JC; Zhang Y; Shi HY Zhonghua Nan Ke Xue; 2008 Apr; 14(4):307-10. PubMed ID: 18481420 [TBL] [Abstract][Full Text] [Related]
14. The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation. Cho KS; Kim J; Choi YD; Kim JH; Hong SJ Med Hypotheses; 2008; 70(3):532-5. PubMed ID: 17761390 [TBL] [Abstract][Full Text] [Related]
15. [Effect of hypertension on cell proliferation and apoptosis in benign prostatic hyperplasia]. Li PJ; Zhang XH; Guo LJ; Na YQ Zhonghua Nan Ke Xue; 2005 Feb; 11(2):94-7. PubMed ID: 15755024 [TBL] [Abstract][Full Text] [Related]
16. [Correlation of benign prostatic hyperplasia with hyperlipemia]. Li PJ; Zhang XH; Guo LJ; Na YQ Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):387-9. PubMed ID: 15854349 [TBL] [Abstract][Full Text] [Related]
17. Clinical and experimental studies of benign prostatic hyperplasia. Coffey DS; Walsh PC Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
19. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. Claus S; Berges R; Senge T; Schulze H J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363 [TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]